Below is a partial list of the companies that
will be presenting at this year's conference

June 1-2, 2016

* Important note about presenting companies

22nd Century Group, Inc.
22nd Century Group, Inc. (XXII)   Day 1
Industry Sector: Retail and Consumer Products

22nd Century Group, Inc., is a plant biotechnology company that provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The company is also developing a prescription smoking cessation aid, which is a tobacco-based botanical medical product; and modified risk cigarettes with approximately 95% less nicotine than conventional tobacco cigarettes, as well as cigarettes that contain low amounts of tar per milligram of nicotine. Through a recent collaboration with Anandia Laboratories, the company gained exclusive U.S. rights to genes required to produce cannabinoids, which are compounds that act on cannabinoid receptors of human cells, the most notable being THC. Technology licensed from Anandia allows for development of cannabis strains that increase or decrease the content of cannabinoids. The company was founded in 1998 and is headquartered in Clarence, New York.

Acme United Corporation
Acme United Corporation (ACU)   Day 1
Industry Sector: Retail and Consumer Products

Acme United Corporation is a leading worldwide supplier of innovative cutting, measuring, first aid and sharpening products to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include Westcott®, Clauss®, Camillus®, Cuda®, PhysiciansCare®, First Aid Only®, Pac Kit® and DMT®. The Company has had six years of increasing sales and earnings, and has been recognized by Forbes, Business Week , and Fortune as among the fastest growing small companies in the U.S.

Akoustis Technologies Inc.
Akoustis Technologies Inc. (AKTS)   Day 1
Industry Sector: Technology - Media and Internet

Akoustis™ is a high-tech RF filter solutions company that manufactures its unique, patent-pending Bulk ONE™ acoustic wave technology to produce single-crystal bulk acoustic wave (BAW) filters for the mobile-wireless industry, which facilitates signal acquisition and accelerates band performance between the antenna and the back end of mobile devices. The Bulk Acoustic Wave (BAW) filter market is rapidly expanding, driven by growth in 4G/LTE and the number of filters required per device. Akoustis' "fabless" business model is capital efficient, leveraging existing manufacturing infrastructure in the semiconductor industry. Akoustis™ is located in the Piedmont technology corridor between Charlotte and Raleigh, North Carolina. The company was founded in 2014 by experienced industry leaders and scientists from University of California at Santa Barbara (UCSB) and Cornell University.

Alcentra Capital Corporation
Alcentra Capital Corporation (ABDC)   Day 1
Industry Sector: Financials and Asset Management Services

Alcentra Capital Corporation provides customized debt and equity financing solutions to America's growth companies. Alcentra specializes in investments in lower middle-market companies in such fast growing business segments as healthcare, pharmaceutical services, telecommunications, cyber security, information technology, business services, defense, and aerospace.

Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. (AMBS)   Day 1
Industry Sector: Life Science and Healthcare

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.

Antibe Therapeutics
Antibe Therapeutics (ATBPF)   Day 2
Industry Sector: Life Science and Healthcare

Antibe is a commercial-stage pharmaceutical company focused on building a portfolio of high value commercial and pre-approval assets in the areas of pain, inflammation and regenerative medicine. Antibe's lead drug, ATB-346, targets the global need for a safer non-steroidal anti-inflammatory drug ("NSAID") for treating chronic pain and inflammation. ATB-352, the second drug in Antibe's pipeline, targets the urgent global need for a safer analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Antibe's subsidiary, Citagenix Inc. ("Citagenix"), is a leader in the sales and marketing of tissue regenerative products servicing the orthopedic and dental marketplaces. Since its inception in 1997, Citagenix has become the largest source of knowledge and experience in the Canadian medical device industry. Citagenix Inc. is active in 15 countries, operating in Canada through its direct sales teams, and internationally via a network of distributor partnerships.

Apivio Systems Inc.
Apivio Systems Inc. (APV)   Day 2
Industry Sector: Technology - Media and Internet

Apivio Systems Inc. is a leader in the design and development of VoIP communications equipment and software. The Company's vision is that one day all enterprise phones will be smart phones and it has developed and sold Android deskphones for resale to its partner, NEC. In executing its vision, Apivio aims to disrupt the enterprise phone market. It has a wholly owned Korean subsidiary that is the market share leader in supplying VoIP centrex phones to all the major Korean phone companies. In 2015, the Company generated C$60M in revenue, with C$2.1M in EBITDA and C$1M in net income.

AstroNova (ALOT)   Day 2
Industry Sector: Technology - Media and Internet

Astro-Med, Inc., d/b/a AstroNova, a global leader in data visualization technologies, designs, manufactures, distributes and services a broad range of products that acquire, store, analyze and present data in multiple formats. The Product Identification segment offers a variety of hardware and software products and associated consumables that allow customers to mark, track and enhance the appearance of their products. Major brands include QuickLabel®, the industry leader in onsite color label printing. The Test and Measurement segment includes the T&M Product Group, which offers a suite of products and services that acquire and record electronic signal data from local and networked sensors. The Test and Measurement segment also includes a line of Aerospace Products that are used in aircraft flight decks and cabins to record, print and display data. Astro-Med, Inc. is a member of the Russell Microcap® Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO).

Aurora BioPharma
Aurora BioPharma Private   Day 1
Industry Sector: Life Science and Healthcare

Aurora BioPharma is a biotechnology company based in Cambridge, Massachusetts commercializing cutting-edge cancer adoptive cell immunotherapy, with CAR T cells in liquid and solid to tumors. The Company has completed two clinical trials in genetically reprogrammed CAR T cell therapy in solid tumor, Glioblastoma and Sarcoma. A Phase I/II trial with its CAR T agent AU-101 was completed in 19 Sarcoma (16 Osteosarcoma) patients, that met its endpoint of safety, with strong signs of tumor killing efficacy, and survival benefits. Aurora also completed a CAR T trial with its agent AU-105 in Glioblastoma that showed safety, with strong signals of ORR and up to double the historic survival benefit.

An ongoing Phase I/II trial with AU101 including lympodepletion in Osteosarcoma is currently recruiting. A Phase I/II trial with Au101 with local delivery is recruiting in Recurrent Glioblastoma.

A randomized high powered phase IIB/III is planned with AU105 in Newly Diagnosed Glioblastoma for the Fall 2016. A phase II trial is planned in metastatic Breast cancer with AU101 for Fall 2016.

Avalon Advanced Materials Inc.
Avalon Advanced Materials Inc. (AVLNF)   Day 1
Industry Sector: Energy and Natural Resources

Avalon Advanced Materials Inc. (formerly Avalon Rare Metals Inc.) is a Canadian mineral development company with a primary focus on the rare metals and minerals, headquartered in Toronto, Canada. Avalon specializes in niche market metals and minerals with growing demand in new technology. The company has three advanced stage projects, all 100%-owned, providing investors with exposure to lithium, tin and indium, as well as rare earth elements, tantalum, niobium and zirconium. Avalon is currently focusing on its Separation Rapids Lithium Project near Kenora, Ontario, which has the potential to produce a high purity lithium concentrate for two separate markets: an industrial mineral product for the glass-ceramics sector and high purity lithium compounds for energy storage. Health and safety, social responsibility and leadership in environmental stewardship are corporate cornerstones.

Avant Diagnostics, Inc.
Avant Diagnostics, Inc. (AVDX)   Day 1
Industry Sector: Life Science and Healthcare

Avant is a medical diagnostic technology company that specializes in biomarker tests that are based on querying large panels of proteins with exquisite precision. We are developing specialized tests that are cutting edge in medical testing and our OvaDx® Pre-Symptomatic Ovarian Cancer Screening Test is a leading breakthrough in commercializing these tests." Avant's first test, OvaDx®, is proposed for use in monitoring women diagnosed previously with ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to ovarian tumor cell development. Pre-clinical research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA 510(k) clearance, Avant intends to sell or license OvaDx®. Avant intends to utilize its public company stage to expand its portfolio of diagnostic tests in the future.

AYTU Bioscience, Inc.
AYTU Bioscience, Inc. (AYTU)   Day 1
Industry Sector: Life Science and Healthcare

Aytu BioScience is a commercial-stage specialty healthcare company focused on global commercialization of novel products in the field of urology. Aytu's current portfolio of commercial and late-stage urology products addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction, and the company plans to expand into other urological indications for which there are significant medical needs. The Company currently markets ProstaScint® (capromab pendetide), the only radio-labeled monoclonal antibody that targets prostate specific membrane antigen (PSMA), a protein highly expressed by prostate cancer cells. ProstaScint is FDA-approved as an imaging agent for use in both newly diagnosed, high-risk prostate cancer patients and patients with recurrent prostate cancer. Aytu also markets Primsol® (trimethoprim hydrochloride) – the only FDA-approved trimethoprim-only oral solution for urinary tract infections. Additionally, Aytu markets the CE Marked MiOXSYS™ System outside the U.S. and is conducting U.S.-based clinical trials, following which the Company expects to receive 510k de novo medical device clearance. The MiOXSYS System is a novel, rapid semen analysis system with the potential to become a standard of care in the diagnosis and management of male infertility. MiOXSYS is the only rapid test for assessing oxidative stress in semen and seminal plasma, a leading contributor of idiopathic male infertility. Aytu's strategy is to continue building its portfolio of revenue-generating urology products and late-stage development assets, leveraging its commercial team and expertise to further build those brands within well-established markets.

Be Active Brands, Inc.
Be Active Brands, Inc. (JALA)   Day 1
Industry Sector: Retail and Consumer Products

Be Active Brands, Inc. is a manufacturer and marketer of Greek frozen yogurt under the Jala brand. The Company manufactures and sells low fat, low calorie, all natural probiotic enriched Greek frozen yogurt under the trade name Jala. Its Greek frozen yogurt is packaged as low fat bars and pints, which are designed to appeal both the health conscious and weight conscious consumer. The Company produces high quality, low fat, low calorie, all natural novelty frozen yogurt and ice cream products. Its proprietary Greek frozen yogurt is all fat-free and is a result of its proprietary recipe and the quality of the ingredients in the mix.

BG Staffing
BG Staffing (BGSF)   Day 2
Industry Sector: Software and Business Services

Headquartered in Plano, Texas, BG Staffing is a national provider of temporary staffing services across a diverse set of industries. The Company has grown revenue from approx. $40 million in 2010 to $217 million in 2015 (approx. 25% increase over 2014), through both organic growth and accretive acquisitions. The Company pays a $0.25 quarterly dividend. L. Allen Baker, Jr., President and CEO, has been in the staffing industry since 1985, having made more than 20 successful acquisitions in his career. At BGSF, Baker has closed and successfully integrated seven accretive acquisitions.

BIO-key International, Inc.
BIO-key International, Inc. (BKYI)   Day 2
Industry Sector: Software and Business Services

BIO-key is revolutionizing security and user authentication, as our easy-to-use biometric solutions enable convenient and secure information access and transactions, whether in-person or online. Our state-of-the-art software solutions eliminate the need for passwords, PINs, tokens and cards, and make it easy for enterprises and consumers to secure their devices as well as their information in the cloud. In addition, BIO-key’s finger scanning devices SideTouch, SideSwipe and EcoID offer market leading quality, performance and price.

BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (BRTX)   Day 2
Industry Sector: Life Science and Healthcare

BioRestorative Therapies develops therapeutic products primarily involving adult stem cells.

Disc/Spine: BRTX-100 is a product formulated from autologous mesenchymal stem cells collected from bone marrow. We intend that the product will be used for the non-surgical treatment of lumbar discs in patients suffering from chronic lumbar disc disease. BRTX-100 is injected into the patient's damaged disc in an outpatient procedure. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery.

Metabolic: Allogeneic therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. Initial research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

BioSculpture Technology, Inc.
BioSculpture Technology, Inc. (Private)   Day 2
Industry Sector: Life Science and Healthcare

BioSculpture Technology, Inc. ("BST") is a commercial stage medical device manufacturer developing a patented and prototyped minimally invasive procedure and device for the direct endoscopic removal of visceral or "belly" fat as a new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus.  We believe our method and device will save lives, improve life outcomes, and significantly reduce healthcare costs.

2/3 of the U.S. population is overweight and 43% is forecast to be obese in a few years.  Obesity related disease expenditures exceeded $2 Trillion and obesity medical device expenditures exceeded $2.0 Billion in 2015.  Current bariatric procedures are highly invasive, involve significant risks and life-changing compromises.  There is an enormous unmet need for a minimally invasive treatment of obesity that is safer and highly effective. 

BST plans a tier 2 Reg. A Offering to bring this treatment to the billions of obese patients who can benefit from it.

BioSig Technologies, Inc.
BioSig Technologies, Inc. (BSGM)   Day 1
Industry Sector: Life Science and Healthcare

BioSig Technologies, Inc. is an emerging-growth medical device company that is developing a proprietary technology platform aimed at the rapidly growing $3 billion electrophysiology marketplace. A proven management team, world-class Board of Directors and renowned Scientific Advisory Board, leads the Minneapolis based company. Currently, the Company is preparing to commercialize their PURE EP™ System. PURE EP is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time. PURE EP acquires and displays high-fidelity cardiac signal recordings at previously undetectable levels with astounding accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that otherwise create a heart rhythm disturbance (arrhythmia). PURE EP is an innovative platform, that offers life-saving benefits compared to competitors' technologies; including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of repeat procedures.

Biostage Inc.
Biostage Inc. (BSTG)   Day 2
Industry Sector: Life Science and Healthcare

Biostage is a biotechnology company developing bioengineered organ implants based on the company's new CellframeTM technology which combines a proprietary biocompatible scaffold with a patient's own stem cells to create CellspanTM organ implants. Cellspan implants are being developed to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of dramatically improving the treatment paradigm for patients. Based on its preclinical data, Biostage has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.

Cellspan implants are currently being advanced and tested in a collaborative preclinical study. This testing is intended to expand the base of preclinical data in support of Biostage's goal of filing an Investigational New Drug (IND) application with the U.S. FDA in late 2016. The IND will seek approval to initiate clinical trials for its esophageal implants in humans.

Blue Citadel Technologies
Blue Citadel Technologies Private   Day 2
Industry Sector: Technology - Media and Internet

Growing plants indoors will never be the same…

Exclusive, revolutionary plant growing technology creates new business opportunities

Introducing the world's most advanced and energy-efficient ALL-IN-ONE SYSTEM for indoor growers, featuring optimal growth-promoting lightwaves and management of other plant growth parameters. Using patent-pending disruptive technology developed by its R&D team, Blue Citadel Technologies offers exciting, high-yield solutions for vertical farming, urban agriculture and cannabis production.

A private Canadian company with strong European ties, Blue Citadel Technologies is a world leader in state-of-the-art lighting systems. Extensive testing and quality control ensures its new all-in-one growing system will perform at maximum efficiency and deliver superior reliability. Worldwide marketing rights have been secured. Distribution to wholesale and retail markets is planned for Q3 of 2016 in Africa, Europe and North America.

Blue Sphere Corporation
Blue Sphere Corporation (BLSP)   Day 1
Industry Sector: Energy and Natural Resources

Blue Sphere Corporation is an international Independent Power Producer (IPP) that is globally active in the clean energy production and waste-to-energy markets. Blue Sphere is becoming a key player in these rapidly growing markets by developing or acquiring facilities that use clean energy technologies. The Blue Sphere waste-to-energy facilities generate long-term predictive revenue streams by selling electricity, natural gas, compost and other by-products primarily through fixed-rate power purchase agreements. The waste-to-energy markets provide tremendous opportunity, insofar as there is a virtually endless supply of waste and organic material that can be used to generate power and valuable by-products. In particular, the disposal of organic material to landfills in most parts of the world is a costly problem with environmentally-damaging consequences. Blue Sphere offers a cost-effective, environmentally-safe alternative.

Bridgeline Digital Inc.
Bridgeline Digital Inc. (BLIN)   Day 2
Industry Sector: Software and Business Services

Bridgeline Digital, The Digital Engagement Company™, helps customers maximize the performance of their full digital experience – from websites and intranets to online stores and campaigns. Bridgeline’s iAPPS platform deeply integrates Web Content Management, eCommerce, eMarketing, Social Media management, and Web Analytics to help marketers deliver digital experiences that attract, engage and convert their customers across all channels. Headquartered in Burlington, Mass., Bridgeline has thousands of quality customers that range from small- and medium-sized organizations to Fortune 1000 companies.

Caliber Companies
Caliber Companies   Day 1
Industry Sector: Financials and Asset Management Services

Caliber builds wealth through acquiring, renovating and managing real estate. The Company is headquartered in Scottsdale, AZ with offices in Tucson and operations throughout Phoenix, Tucson & Flagstaff. In 7 years, Caliber has grown from a start-up with no initial capital to a full-service investment firm that has acquired and repositioned over $200 million in commercial, residential, multifamily and hospitality real estate throughout the greater southwest. Caliber's growth is attributed to a leadership team that believes in the power of strong relationships, honor in dealings, integrity, responsibility, transparency and discipline. Caliber is at the forefront of investor sentiment toward alternative investment options. We provide access.

Capnia, Inc.
Capnia, Inc. (CAPN)   Day 1
Industry Sector: Life Science and Healthcare

Capnia, Inc. develops and commercializes novel products based on its proprietary technologies for precision metering of gas flow. Capnia's lead product CoSense® is based on the Sensalyze™ Technology Platform. It is a portable, non-invasive device that rapidly and accurately measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal sources (such as hemolysis, a dangerous condition in which red blood cells degrade rapidly), as well as external sources (such as CO poisoning and smoke inhalation). The initial target market is newborns with jaundice that are at risk for hemolysis, comprising approximately three million births in the U.S. and European Union. Capnia's proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being evaluated to treat the symptoms of allergies, as well as the trigeminally mediated pain conditions such as cluster headache, trigeminal neuralgia and migraine.

Car Charging Group, Inc.
Car Charging Group, Inc. (CCGI)   Day 2
Industry Sector: Energy and Natural Resources

Car Charging Group, Inc. is a pioneer in nationwide public electric vehicle (EV) charging services, enabling EV drivers to easily recharge at locations throughout the United States. Headquartered in Miami Beach, FL with offices in Las Gatos, CA; New York, NY; and Phoenix, AZ; CarCharging's business model is designed to accelerate the adoption of public EV charging.

CarCharging offers commercial EV charging hardware and software. Through its subsidiary, Blink Network, CarCharging also provides residential EV charging solutions for single-family homes.  For more information, please visit

CarCharging has strategic partnerships across multiple business sectors including multi-family residential and commercial properties, parking garages, shopping malls, retail parking, and municipalities.

Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. (CLRB)   Day 2
Industry Sector: Life Science and Healthcare

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar's PDC Delivery Platform is based on the company's proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. Cellectar's PDC pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. The Company's lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. CLR 131 is currently being evaluated under an orphan drug designated Phase 1 study in patients with relapsed or refractory multiple myeloma. The company is also developing PDCs for targeted delivery of chemotherapeutics such as paclitaxel (CLR 1602-PTX), a pre-clinical stage product candidate, and plans to expand its PDC chemotherapeutic pipeline through both in-house and collaborative R&D efforts.

Cel-Sci Corp
Cel-Sci Corp (CVM)   Day 2
Industry Sector: Life Science and Healthcare

CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.

Cesca Therapeutics
Cesca Therapeutics (KOOL)   Day 1
Industry Sector: Life Science and Healthcare

Cesca Therapeutics is engaged in research, development and commercialization of cellular therapeutics and devices for use in regenerative medicine and hematological and oncological applications. We serve patients, physicians and partners through technologies that address cellular therapeutics, medical/diagnostic devices, cell manufacturing and cryopreservation. Along with our proprietary automated devices for concentration of therapeutic stem cells from blood, we are currently undertaking an FDA-approved pivotal trial to treat late stage critical limb ischemia (CLI) with our SurgWerks™ Platform for the delivery of regenerative cell therapy for vascular disease and orthopedic indications.

The Company is based out of Rancho Cordova, California, with offices in Emeryville, California and Delhi, India.

Chimes Broadcasting, Inc.
Chimes Broadcasting, Inc. (Private)   Day 2
Industry Sector: Technology - Media and Internet

Chimes is to music, what IMDB is to movies. is in the top 10 largest web site audiences in the US, and generally in top 3 search results on google searches about movies, TV shows, or actors. Chimes is a massive music database, developed overseas at already $24MM and counting, containing product credits, recording artists, compositions, tracks, albums, genre, bands and more; like IMDB, we expect our web site to ultimately be in the top. Our model has high margins and low operating costs, low COGS, exploiting eCommerce and programmatic advertising. This asset will soon be monetized in the US for the first time, on web/mobile, planning a 2017 NASDAQ offering. Management has significant, relevant, experience is digital media, technology, internet, and music, having previously run companies on the NASDAQ and TSX.

ChromaDex Corporation
ChromaDex Corporation (CDXC)   Day 1
Industry Sector: Life Science and Healthcare

ChromaDex Corp. is a natural products company that leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to the Company's proprietary ingredient technologies segment, the Company also has a core standards and contract services segment, which focuses on natural product fine chemicals (known as "phytochemicals") and chemistry and analytical testing services and a regulatory consulting segment (known as Spherix Consulting). As a result of the Company's relationships with leading universities and research institutions, the Company is able to discover and license early stage, intellectual property-backed ingredient technologies. The Company then utilizes the Company's business segments to develop commercially viable proprietary ingredients. The Company's proprietary ingredient portfolio is backed with clinical and scientific research, as well as extensive intellectual property protection.

Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR)   Day 1
Industry Sector: Life Science and Healthcare

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes therapeutic products. They offer Suprenza ODT, a phentermine orally disintegrating tablet, used for the treatment of obesity. Its products also include Hydrocortisone-Lidocaine Cream, which is under phase II of clinical trial for the treatment of hemorrhoids. The company has a collaboration and license agreement with Alpex Pharma S.A. to develop and commercialize orally disintegrating tablet formulations of pharmaceutical products throughout North America. Recently, they announced that they were acquiring Leonard Meron, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. Founder and CEO, Leonard Mazur previously served as Executive VP at Medicis Pharmaceutical Corporation and VP of Sales & Marketing at ICN Pharmaceuticals, Inc. (Now Valeant)/, Knoll Pharma, (Unit of BASF). Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Maynard, Massachusetts.

Coffee Holding Company, Inc.
Coffee Holding Company, Inc. (JVA)   Day 1
Industry Sector: Retail and Consumer Products

Coffee Holding Company is a horizontally and vertically integrated coffee roaster with a 45 year history of success in the highly fragmented and highly competitive coffee industry. Our horizontally integrated business model, selling both roasted and raw green specialty Arabica coffees to both large retailers and smaller regional roasters, has allowed us to maintain profitability in the varying commodity and economic cycles over the past four and one half decades. We have an international presence in the industry with sales throughout North America, the Caribbean, Europe and the Pacific Rim. Our vertical integration, where we source at Farmgate, has given us direct access to a stable supply of high quality coffee beans which we roast and resell to our customers ensuring their continued satisfaction and loyalty to our company, enabling us to grow both our top line revenues, customer base and overall reputation within the industry.

CohBar, Inc.
CohBar, Inc. (CWBR)   Day 2
Industry Sector: Life Science and Healthcare

CohBar, Inc. is a leader in the research and development of mitochondria-based therapeutics (MBTs), an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders. We are currently selecting a clinical candidate for our lead program, MOTS-c, prior to initiating IND enabling studies.

CombiMatrix Corporation
CombiMatrix Corporation (CBMX)   Day 2
Industry Sector: Life Science and Healthcare

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in prenatal diagnostics, miscarriage analysis /recurrent pregnancy loss, pediatric genetics and pre-implantation genetic screening, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making.

ContraVir Pharmaceuticals
ContraVir Pharmaceuticals (CTRV)   Day 1
Industry Sector: Life Science and Healthcare

ContraVir is a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies with two candidates in mid-to-late stage clinical development. ContraVir’s lead clinical drug, FV-100, is an orally available nucleoside analogue prodrug that is being developed for the treatment of herpes zoster, or shingles, which is currently in Phase 3 clinical development. In addition to direct antiviral activity, FV-100 has demonstrated the potential to reduce the incidence of debilitating shingles-associated pain known as post-herpetic neuralgia (PHN) in a Phase 2 clinical study. ContraVir is also developing CMX157, a highly potent analog of the successful antiviral drug tenofovir, for the Hepatitis B virus. CMX157’s novel structure results in decreased circulating levels of tenofovir, lowering systemic exposure and thereby reducing the potential for renal and bone side effects.

COPsync, Inc.
COPsync, Inc. (COYN)   Day 1
Industry Sector: Technology - Media and Internet

COPsync is America’s largest law enforcement real-time information sharing, communication and data interoperability Network. With COPsync, officers instantly access local, state, and federal law enforcement databases, efficiently gather information at the point of incident, and immediately share critical data with all officers on the COPsync Network.

CorMedix Inc
CorMedix Inc (CRMD)   Day 2
Industry Sector: Life Science and Healthcare

CorMedix is a commercial-stage pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease. The Company's first commercial product in Europe is Neutrolin®, a novel non-antibiotic anti-infective solution for the prevention of catheter-related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access for hemodialysis, oncology, critical/intensive care, and patients receiving total parenteral nutrition, IV hydration, and/or IV medications. In December 2015, CorMedix initiated a Phase 3 clinical study of Neutrolin in hemodialysis patients in the United States, for which the Company expects to report interim data by year end 2016. The FDA has granted Fast Track status to Neutrolin and also has designated Neutrolin as a Qualified Infectious Disease Product for oncology, hemodialysis, and critical care/intensive care patients, where catheter-related blood stream infections and clotting can be life-threatening.

Curtana Pharmaceuticals
Curtana Pharmaceuticals Private   Day 2
Industry Sector: Life Science and Healthcare

Curtana Pharmaceuticals is developing the first truly targeted small molecule therapeutics for the treatment of a variety of brain cancers, including glioblastoma in adults and pediatric high grade glioma in children. Founded in 2013, Curtana is located in Austin, TX. To-date, the company has raised nearly $9M in financing, the majority of which was non-dilutive. The company’s clinical candidate, CT-179, blocks the function of Olig2, a transcription factor that is highly expressed in all diffuse gliomas. Olig2 drives tumor growth and invasiveness as well as regulates the survival and expansion of the cancer. CT-179 can be taken by mouth, has excellent drug-like properties, crosses the blood-brain barrier, achieves very high concentrations in the brain, and significantly prolongs survival in a mouse brain cancer model. The filing of an IND application for CT-179 is planned to occur in H1 2017.

Dataram Corporation
Dataram Corporation (DRAM)   Day 2
Industry Sector: Technology - Media and Internet

Dataram Corporation is a leading independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops. The Company's memory products and solutions are sold worldwide to OEMs, distributors, value-added resellers, end users and leading manufacturers such as Dell, Cisco, Fujitsu, HP, IBM, Lenovo and Oracle. Founded in 1967, the Company has established a rich history and strong presence in the United States, Europe and Asia. Over the past 14 months, Dataram with investor support has appointed new leadership (CEO, CFO, and Board of Directors) to refocus and bring the Company back to sustainability and profitability which it is projected to achieve in the first two quarters of full year 2016. The turnaround strategy has already delivered more than $4 million in net cash savings to date.

Diagnostic Lab Corporation
Sponsoring Presenting Company
Diagnostic Lab Corporation Private   Day 2
Industry Sector: Life Science and Healthcare

Diagnostic Lab Corporation (DLC) is the first third party certification firm in Cannabis. Through it's online portal and its safety audit and compliance protocols, DLC insures product quality, safety and truth in labeling for all medical and recreational products. DLC with its propriety IP, including relationships with the Israeli Government, growers and manufactures (not only in the US) but globally, best-in-class food safety, medical cannabis and legal/ compliance professionals has created a simple, easy to use, business friendly system. It utilizes traditional fundamentals but maintains a social media valuation.

Direct Insite Corp
Direct Insite Corp (DIRI)   Day 1
Industry Sector: Software and Business Services

Direct Insite™ provides a powerful platform for unified working capital management that facilitates over $160 billion worth of transactions annually between more than 375,000 companies worldwide.  Direct Insite’s clients include IBM, Siemens, BE Aerospace, Saint Gobain, Carlson, and one of the largest financial institutions in the world.  The flagship component of Direct Insite’s unified working capital management platform is PAYBOX™, an innovative receivables automation solution that combines electronic invoicing, online approvals and adjustments, electronic payments, and integration with any legacy accounting, ERP or lockbox system.  PAYBOX™ is primarily sold through banks to corporate users of their treasury management and lockbox services.  Banks and corporations use PAYBOX™ to reduce Days Sales Outstanding, lower costs, and improve straight-through AR posting.

Dyadic International, Inc.
Dyadic International, Inc. (DYAI)   Day 1
Industry Sector: Life Science and Healthcare

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant protein production system based on the fungus Myceliopthora thermophila, nicknamed C1. The C1 microorganism, which enables the development and large scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development and production of biologic drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines, monoclonal antibodies, biosimilars and/or biobetters, and other therapeutic proteins. Dyadic pursues research & development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in developing and manufacturing biopharmaceuticals which these technologies help produce. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic drugs to market faster, in greater volumes and at lower cost to drug developers and manufacturers and, hopefully, improve access and cost to patients and the healthcare system.

Ember Therapeutics, Inc.
Ember Therapeutics, Inc. (EMBT)   Day 1
Industry Sector: Life Science and Healthcare

Ember Therapeutics, Inc. is a pharmaceutical company developing targeted therapies for pain, osteoarthritis, kidney fibrosis and other regenerative medicines. In particular, Ember Therapeutics, Inc. has a commercial stage pain product and two late stage Phase 3 ready assets.

Emerald Medical Applications Corp.
Emerald Medical Applications Corp. (MRLA)   Day 2
Industry Sector: Life Science and Healthcare

Emerald Medical Applications owns the Dermacompare Medical App. Dermacompare is a cloud based, artificial intelligence technology that enables photos, taken from almost all digital cameras, to detect the suspicion of Melanoma. Through its FDA registered, HIPPA compliant App, which can be downloaded from any App store, the individual and/or the doctor can use almost any camera to identify suspicious Melanoma moles automatically by comparing the photos, versus Emerald’s cloud database of over 50 million known moles, as well as the patient’s previous pictures. This technology dramatically enhances the doctor’s ability to detect Melanoma by being more accurate in a more efficient manner.

Endonovo Therapeutics
Endonovo Therapeutics (ENDV)   Day 2
Industry Sector: Life Science and Healthcare

Endonovo Therapeutics is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating and preventing vital organ failure through the reduction of inflammation and the promotion of regeneration. Endonovo is initially concentrating on treating acute inflammatory conditions in the liver using its non-invasive Immunotronics platform. Endonovo's Cytotronics™ platform uses Time-Varying Electromagnetic Fields (TVEMF) for expanding and optimizing the therapeutic potential of stem cells and for the production of fully human biomolecules. The Company is initially concentrating on the creation of next generation cell therapies that have been enhanced using bioelectronics for the treatment of Graft-Versus-Host Disease (GvHD).

eWellness Healthcare Corporation
eWellness Healthcare Corporation (EWLL)   Day 2
Industry Sector: Life Science and Healthcare

eWellness Healthcare Corporation is the first physical therapy telemedicine company to offer insurance reimbursable real-time distance monitored treatments. Our business model is to license our PHZIO ("PHZIO") platform to any physical therapy clinic in the U.S. and or have large-scale employers use our PHZIO platform as a fully PT monitored corporate wellness program. The Company's PHZIO home physical therapy exercise platform has been designed to disrupt the $30 billion physical therapy and the $8 billion corporate wellness industries. PHZIO re-defines the way physical therapy can be delivered. PHZIO is the first real-time remote monitored 1-to-many physical therapy platform for home use. Due to the real-time patient monitoring feature, the PHZIO platform is insurance reimbursable by payers such as: Anthem Blue Cross and Blue Shield.

EyeGate Pharmaceuticals Inc.
EyeGate Pharmaceuticals Inc. (EYEG)   Day 2
Industry Sector: Life Science and Healthcare

EyeGate Pharma is a late-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. EyeGate’s technology addresses two of the most prevalent issues in ophthalmic care; the existing lack of patient adherence and patient safety. EyeGate Pharma is committed to advancing their delivery technology and therapeutic candidates with a goal of bringing new, potentially superior treatment options to patients who will most likely benefit.  

Finjan Holdings, Inc.
Finjan Holdings, Inc. (FNJN)   Day 1
Industry Sector: Technology - Media and Internet

Finjan, founded in 1997, is a technology company committed to investing in and enabling technology innovation. Our early technology innovations and products helped define the state-of-the-art for detecting and deflecting software intrusions and malicious code delivery, over internet and private networks, to devices located at endpoint connections. Beginning with the formation of the company, we have invested considerable time, effort and resources to secure our inventions with US and Foreign patents. As Finjan’s patented technologies have become increasingly relevant across today’s growing security sector, we continue to seek licenses to our patents across the industry. Finjan has successfully licensed its patents to a number of industry players, demonstrated a strong commitment to pursuing unlicensed companies through litigation, resulting in more than $145 million in licensing revenues, to date. The company continues to invest in the security sector and intends to broaden its technology and intellectual property holdings through continued acquisition, investment, and strategic partnerships.

Fision Corporation
Fision Corporation Private   Day 1
Industry Sector: Software and Business Services

Fision is a cloud-based distributed marketing software that enables corporate and local marketers, sales teams and vendor partners to efficiently store, create, and measure omni-channel marketing communications. By having all sales and marketing communications centralized, organizations can drastically improve efficiencies at the local/individual user level, optimize distribution channels, ensure brand and regulatory compliance, get better insight through a larger aggregated data set, and make better business decisions.

FTE Networks, Inc.
FTE Networks, Inc. (FTNW)   Day 1
Industry Sector: Technology - Media and Internet

FTE Networks, Inc. designs, builds, and supports wireless and wireline networking infrastructures for the IT and telecommunications industries. We enable our customers to connect to their customers by providing a high performance networking infrastructure to ensure fast, reliable and secure voice, data and digital content delivery.

With our integrated end to end networking engineering approach, wealth of industry experience and strong customer relationships, FTE helps companies expand their market presence, improve performance and agility, and control costs.

Founded in 2007, FTE Networks, Inc. is headquartered in Naples, Florida, with offices throughout the United States and Europe.

Fuling Global Inc.
Fuling Global Inc. (FORK)   Day 1
Industry Sector: Industrials

Fuling Global Inc. ("Fuling Global") is a specialized producer and distributor of environmentally friendly plastic serviceware, with precision manufacturing facilities in both the U.S. and China. The Company's plastic serviceware products include disposable cutlery, drinking straws, cups, plates and other plastic products and are used by more than one hundred customers primarily from the U.S. and Europe, including Subway, Wendy's, Burger King, KFC (China only), Walmart, McKesson, and Woolworths.

General Employment Enterprises, Inc.
General Employment Enterprises, Inc. (JOB)   Day 2
Industry Sector: Software and Business Services

General Employment Enterprises, Inc. was incorporated in the State of Illinois in 1962, is a provider of specialized staffing solutions and is the successor to employment offices doing business since 1893. The Company operates in two industry segments, providing professional staffing services and solutions in the information technology, engineering, finance and accounting specialties and light industrial staffing services through the names of General Employment, Access Data Consulting, Agile Resources, Ashley Ellis, Omni-One, Paladin Consulting and Triad. Also, in the healthcare sector, General Employment, through its Scribe Solutions brand, staffs medical scribes who assist physicians in emergency departments of hospitals and in medical practices by providing required documentation for patient care in connection with electronic medical records (EMR).

Global Self Storage, Inc.
Global Self Storage, Inc. (SELF)   Day 2
Industry Sector: Retail and Consumer Products

Global Self Storage, Inc. is a self-administered and self-managed real estate investment trust ("REIT") focused on the ownership, operation, acquisition, development and redevelopment of self storage facilities in the United States. Our self storage facilities are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. The Company currently owns and operates, through its wholly owned subsidiaries, seven self storage properties located in New York, Pennsylvania, Illinois, Indiana, and South Carolina.

Great Basin Scientific
Great Basin Scientific (GBSN)   Day 2
Industry Sector: Life Science and Healthcare

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease.

Green PolkaDot Box Incorporated
Green PolkaDot Box Incorporated (GPDB)   Day 1
Industry Sector: Retail and Consumer Products

Green PolkaDot Box Incorporated ("GPDB" or the "Company"), a publicly traded company, is an online food distributor that is solving enormous food problems in the United States: (1) the high cost and limited availability of CLEAN foods; and (2) the proliferation of GMO contaminated foods that have pervaded more than 70% of the food supply.

GPDB specializes in the provisioning and sales of thousands of popular brand organic and non-GMO or "CLEAN" foods to its growing collective Health Merchants™ and their customers. Health Merchants use GPDB proprietary marketing technology and creative content to market and sell GPDB's CLEAN food offering directly to their own customers, while GPDB provides the infrastructure and logistics for their orders and fulfillment.

GPDB has already enrolled 276 Health Merchants that reach over 45-million customers and its numbers are growing rapidly.

Grom Social, Inc.
Sponsoring Presenting Company
Grom Social, Inc. (Private)   Day 1
Industry Sector: Technology - Media and Internet

Grom Social, Inc., ("Grom"), an exciting pre-IPO opportunity, is a highly interactive social media platform/website, "By Kids for Kids", founded by 12 year old Zach Marks. In three years, Grom has grown to nearly 3 million users in over 200 countries and territories and has been publicized in 375 media outlets.

In recent months under the direction of Sander Schwartz, the Company's president and former president at Warner Brothers Animation, the Company has assembled an advisory board made up of industry titans. In addition, it has completed an acquisition of an interactive social media company and signed a binding LOI to acquire a profitable animation company, subject to obtaining financing, which will be immediately accretive.

The Company is now positioned to become the "Media Destination for Kids in the 21st Century", think "Kids Facebook Meets Instagram with a Touch of Disney Animation Magic"., Inc., Inc. (HEWA)   Day 1
Industry Sector: Technology - Media and Internet, Inc. is America’s Trusted Online Pharmacy, licensed in 50 states to focus on the out-of-pocket prescription drug market, a market which is expected to grow to over $80 billion in 2016. is currently 1 of less than 45 Verified Internet Pharmacy Practice Websites (“VIPPS”) accredited by the National Association of Boards of Pharmacy (“NABP”) and is the only VIPPS accredited pharmacy licensed in all 50 states that processes out-of-pocket prescriptions online. The Company is a four time winner of the BizRate Circle of Excellence Award for outstanding customer service and satisfaction and was recognized by major consumer publications as having the lowest price among top US pharmacies for commonly prescribed medications.

IEG Holdings Corporation
IEG Holdings Corporation (IEGH)   Day 1
Industry Sector: Technology - Media and Internet

IEG Holdings Corporation is an online unsecured consumer loan lender operating under the brand name, "Mr. Amazing Loans." Via its website, lends $5,000 loans over a term of five years at a 23.9% to 29.9% APR in 17 US states, with plans to expand to 25 US states during 2016. Qualifying customers receive $5,000 the same day of application with zero application fees, establishment fees or prepayment penalties and in return make affordable weekly principal and interest repayments totaling $37.03 a week.

ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd. (IMUC)   Day 2
Industry Sector: Life Science and Healthcare

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Integrity Applications, Inc.
Integrity Applications, Inc. (IGAP)   Day 2
Industry Sector: Life Science and Healthcare

Integrity Applications, Inc. is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes, as well as pre-diabetics. Integrity Applications has developed the GlucoTrack® model DF-F non-invasive glucose monitoring device, which is designed to help people with diabetes obtain glucose level measurements without the pain, inconvenience, incremental cost and difficulty or discomfort of conventional (invasive) spot finger stick devices. The device utilizes a unique, patented simultaneous use of combined technologies in order to gain reliable results. Integrity Applications operates primarily through its wholly-owned Israeli subsidiary, A.D. Integrity Applications, Ltd.

GlucoTrack® Model DF-F obtained a CE Mark approval in Europe and is expected to begin clinical trials in the US in 2016, subject to approval of the clinical trials protocol by the US FDA.

International Western Petroleum, Inc.
International Western Petroleum, Inc. (INWP)   Day 1
Industry Sector: Energy and Natural Resources

International Western Petroleum, Inc. is a Texas-based E&P company that focuses on the acquisition, development, and exploration of crude oil and natural gas properties in Texas. The Company is actively looking to acquire oil and gas properties and apply latest technologies and production know-how to increase acreage, productions and reserves with a focus in the Central West Texas region.

Inventergy Global, Inc.
Inventergy Global, Inc. (INVT)   Day 2
Industry Sector: Technology - Media and Internet

Inventergy Global, Inc. is an intellectual property company dedicated to identifying, acquiring and licensing the patented technologies of market-significant technology leaders. Led by former head of IP licensing at Hewlett-Packard, Joe Beyers, the company draws upon decades of corporate experience and market and technology expertise, as well as industry connections, to assist its clients including Fortune 500 companies, in leveraging the value of their innovations to achieve greater returns. Inventergy leverages an experienced team that has brokered more than $15 billion in IP and technology transactions. The company offers a professional corporate licensing model for IP value creation that provides short-term returns and long-term licensing revenue. The company acquires portfolios in the telecommunications industry primarily in IP multimedia subsystems and voice over IP; and mobile broadband communications segments. Inventergy Global, Inc. is headquartered in Campbell, California.

IZEA (IZEA)   Day 2
Industry Sector: Technology - Media and Internet

IZEA operates the premier online marketplace that connects brands with influential content creators. IZEA creators range from leading bloggers and social media personalities to A-List celebrities and professional journalists. Creators are compensated for developing and distributing unique content on behalf of brands including long form text, videos, photos and status updates. Brands receive influential consumer content and engaging, shareable stories that drive awareness.

Jaguar Animal Health Inc.
Jaguar Animal Health Inc. (JAGX)   Day 1
Industry Sector: Life Science and Healthcare

Jaguar Animal Health, Inc. is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses. Canalevia™ is Jaguar's lead prescription drug product candidate, intended for the treatment of various forms of diarrhea in dogs. SB-300 is Jaguar's prescription drug product candidate for the treatment of gastrointestinal ulcers in horses. Canalevia™ and SB-300 contain ingredients isolated and purified from the Croton lechleri tree, which is sustainably harvested. Neonorm™ Calf and Neonorm™ Foal are the Company's lead non-prescription products. Neonorm™ is a standardized botanical extract derived from the Croton lechleri tree. Canalevia™ and Neonorm™ are distinct products that act at the same last step in a physiological pathway generally present in mammals. Jaguar has nine active investigational new animal drug applications, or INADs, filed with the FDA and intends to develop species-specific formulations of Neonorm™ in six additional target species, formulations of SB-300 in horses, and Canalevia™ for cats and dogs.

LabStyle Innovations Corp.
LabStyle Innovations Corp. (DRIO)   Day 1
Industry Sector: Life Science and Healthcare

LabStyle Innovations Corp. operates in the mHeatlh industry, creating innovative mobile and digital tools that empower users to lead healthier lives. LabStyle's "Real time. Real improvements. Real People." approach is positioning the Company as a major player in the mHealth industry, currently worth $10B and expected to reach $31B by 2020. LabStyle's flagship product, The Dario™ Smart Diabetes Management Solution, is a platform for diabetes management that combines an all-in-one blood glucose meter, native smart phone app (iOS & Android), website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems and insurers. The Dario has launched in several international markets and in the U.S., the largest market in the world for glucose monitoring. LabStyle has been granted patents for its technology.

Legacy Education Alliance, Inc.
Legacy Education Alliance, Inc. (LEAI)   Day 2
Industry Sector: Retail and Consumer Products

Legacy Education Alliance, Inc. is a leading international provider of practical, high-quality, and value-based educational training on the topics of personal finance, entrepreneurship, real estate and financial markets investing strategies and techniques. Legacy Education Alliance was founded in 1996, and through a reverse merger, became a publicly-held company in November 2014. Today we are a global company with approximately 200 employees that has cumulatively served more than two million students from more than 150 countries and territories over the course of our operating history. We manage our business in four segments based on geographic location. These segments include our historical core markets of the United States, Canada, and the United Kingdom, with the fourth segment including all other international markets.

We offer our training through a variety of brands including Rich Dad® Education; Rich Dad Stock Education; Making Money From Property With Martin Roberts; Brick Buy Brick; Building Wealth™; Robbie Fowler Property Academy; Women in Wealth; The Independent Woman; Trade Up Investor Education; and Elite Business Star.

Long Island Iced Tea Corp.
Sponsoring Presenting Company
Long Island Iced Tea Corp. (LTEA)   Day 1
Industry Sector: Retail and Consumer Products

Long Island Iced Tea Corp. operates in the ready-to-drink tea segment of the beverage industry. The Company has developed non-alcoholic, premium iced tea bottled beverages made with quality ingredients that are offered at an affordable price. The Company is currently organized around its flagship brand Long Island Iced Tea, a premium, ready-to-drink, proprietary recipe iced tea sold primarily on the East Coast of the United States through a network of national and regional retail chains and distributors.

Mace Security International, Inc.
Mace Security International, Inc. (MACE)   Day 1
Industry Sector: Retail and Consumer Products

Mace Security international, Inc, located in Cleveland, Ohio, is a diversified manufacturer and provider of personal defense and security products to consumer and business market segments under the world renowned Mace® Brand. Since 1970, Mace® Brand has been the original trusted brand for personal defense sprays, while continuously adding high quality security products to the brand line through the years. Mace® Brand supports their products by providing warranty and educational programs for all of various products and services.

Mace® Brand directly distributes and supports it's branded products and services through strategically targeted customer channels that include mass market retailers, wholesale distributors, independent dealers, e-commerce marketers, and installation service providers.

MagneGas (MNGA)   Day 1
Industry Sector: Energy and Natural Resources

MagneGas® Corporation. The Company owns a patented process that converts various liquid wastes into hydrogen based fuels. These fuels can be used as a replacement to natural gas or for metal cutting. The Company's testing has shown the fuels are faster, cleaner and more productive than other alternatives on the market. They are also cost effective and safe to use with little changeover costs.  The Company currently sells MagneGas® into the metal working market as a replacement to acetylene.

The MagneGas fuel production systems can be set-up locally using various types of feedstock. The Company believes this flexibility can give them an advantage in the Government/Military marketplace as fuels can be manufactured on site from raw materials found locally worldwide and eliminates the time and expense of shipping to the specific location. The Company is planning to establish joint ventures with third parties to construct these supply facilities worldwide.

The Company also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, the Company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications.

Marathon Patent Group
Marathon Patent Group (MARA)   Day 1
Industry Sector: Technology - Media and Internet

Marathon is a patent licensing and commercialization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. The Company's commercialization division is focused on the full commercialization lifecycle which includes discovering opportunities, performing due diligence, providing capital, managing development, protecting and developing IP, assisting in execution of the business plan, and realizing shareholder value.

Medical Transcription Billing Corp.
Medical Transcription Billing Corp. (MTBC)   Day 1
Industry Sector: Life Science and Healthcare

MTBC went public in July 2014, purchasing the assets of three medical billing companies for a combination of cash and stock on the date the IPO closed. These have now been successfully integrated with its existing business. In the same way that athenahealth (Nasdaq: ATHN) currently dominates the healthcare information technology market for large doctor practices, MTBC is targeting the fragmented 1-10 doctor market, with a highly-rated proprietary SaaS platform that integrates revenue cycle management with electronic health records, practice management and mobile health.

New government regulations like ICD-10 are putting pressure on industry participants who lack our technology and access a low cost offshore workforce. 95% of our current global workforce of 2,000 is located in Pakistan, where labor costs are approximately 1/2 the cost of comparable India-based employees and 1/10th the cost of comparable U.S. employees. Our growth strategy includes acquiring such revenue cycle management companies and migrating their customers to our platform, as well as forging strategic partnerships with other industry participants, including electronic health records vendors.

Microlin Bio, Inc.
Microlin Bio, Inc. (MICBE)   Day 2
Industry Sector: Life Science and Healthcare

Microlin Bio, Inc. is a development-stage biotechnology company focused primarily on the development of microRNA therapeutics for the treatment of cancer. We have a broad portfolio of technologies licensed from Ohio State University that includes over 138 pending patent applications and 132 granted patents covering numerous microRNAs.

Midwest Energy Emissions Corp.
Midwest Energy Emissions Corp. (MEEC)   Day 2
Industry Sector: Energy and Natural Resources

Midwest Energy Emissions Corp. delivers patented and proprietary solutions to the global coal-power industry to remove mercury from power plant emissions, providing performance guarantees, and leading-edge emissions services. The U.S. Environmental Protection Agency (EPA) MATS rule requires that all coal- and oil-fired power plants in the U.S. larger than 25 mega-watts must remove roughly 90% of mercury from their emissions starting April 15, 2015. On April 14, 2016, the EPA issued a final supplemental finding upholding the rule and concluding that a cost analysis supports the MATS rule. ME2C expects legal challenges to the rule will continue. ME2C has developed patented technology and proprietary products that have been shown to achieve mercury removal levels compliant with MATS at a significantly lower cost and with less operational impact than currently used methods, while preserving the marketability of fly-ash for beneficial use.

Moleculin Biotech, Inc.
Moleculin Biotech, Inc. (MBRX)   Day 1
Industry Sector: Life Science and Healthcare

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world's largest cancer research center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Our most advanced project, Annamycin, has shown life-saving potential in human clinical trials for the treatment of relapsed and refractory AML.  We believe Annamycin is positioned to become the first approved anthracycline to eliminate cardiotoxicity and avoid multidrug resistance and has the potential to not only increase the survival rate of relapsed and refractory acute leukemia patients, but to significantly increase the number of AML patients who qualify for a curative bone marrow transplant.

NanoViricides, Inc.
NanoViricides, Inc. (NNVC)   Day 2
Industry Sector: Life Science and Healthcare

NanoViricides, Incorporated is a pre-clinical biotech company that has utilized its patented platform technology to rapidly create anti-viral drug candidates in the space of months. These drugs actually destroy, as opposed to merely slowdown, the invading virus in the circulation, on the skin or on the surface of the eye. The Company has tested its drug candidates in over 6,000 animals without evidence of resistance, side effects or toxicity. These tests have been conducted on animals infected with various strains of influenza, HIV, dengue/dengue hemorrhagic fever, Ebola, rabies, adenovirus of the eye as well as herpes infections of the skin and the eye. The Company's 25 scientists work in a large, ultra modern, research, development and manufacturing facility in Shelton, CT. Treatments for various forms of acute herpes infections are now being advanced through the pre-clinical process towards human trials.

NatureBank Asset Management
NatureBank Asset Management (COO)   Day 1
Industry Sector: Energy and Natural Resources

NatureBank specializes in advisory, technology and project investment services applied to sustainable commodities and ecological assets, with a primary focus on cocoa, timber and carbon. We provide our customers with a multidisciplinary approach to investing, managing risk, enhancing asset performance and securing commercial returns. While managing climate change risk, we improve livelihoods and sustainability in project regions. Through our advisory services team and our subsidiary companies, Offsetters and CO2OL, we help organizations understand, reduce and offset their climate impact. With offices in Vancouver, British Columbia; Portland, Oregon; Zurich, Switzerland and Bonn, Germany, our team has a global reach. Our team has worked with over 200 leading business organizations including Aimia, Vancity, lululemon athletica, Catalyst Paper, Harbour Air, HSE - Entega, and Shell Canada Limited.

NioCorp Development Ltd.
NioCorp Development Ltd. (NIOBF)   Day 2
Industry Sector: Energy and Natural Resources

NioCorp is developing a superalloy materials project in Southeast Nebraska that will produce niobium, scandium, and titanium. Niobium is used to produce superalloys as well as High Strength, Low Alloy ("HSLA") steel, which is a lighter, stronger steel used in automotive, structural, and pipeline applications. Scandium is a superalloy material that can be combined with Aluminum to make alloys with increased strength and improved corrosion resistance. Scandium also is a critical component of advanced solid oxide fuel cells. Titanium is used in various superalloys and is a key component of pigments used in paper, paint and plastics and is also used for aerospace applications, armor and medical implants.

Notis Global, Inc.
Notis Global, Inc. (NGBL)   Day 1
Industry Sector: Life Science and Healthcare

Notis Global is a pioneer in the worldwide legal hemp and CBD Oil industry. Specializing in cultivation, extraction and product development, Notis brings an unparalleled set of skills and executive experience to the burgeoning hemp industry. Through partnerships, Notis is a leading U.S.-based provider of CBD Oil and holds a significant ownership stake in one of the largest hemp farms in the United States.

Nuvo Pharmaceuticals Inc.
Nuvo Pharmaceuticals Inc. (NRI)   Day 2
Industry Sector: Life Science and Healthcare

Nuvo is a growing, profitable commercial healthcare business with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo Pharma has three FDA approved commercial products that are sold in a number of countries, Pennsaid 2%, Pennsaid and the HLT Patch. Nuvo Pharma’s lead product, Pennsaid 2%, is marketed in the United States by Horizon Pharma. Nuvo Pharma is focused on making Pennsaid 2% a global brand by out-licensing its marketing rights, as well as strategic acquisitions and new contract manufacturing opportunities to increase its commercial product portfolio and to expand its royalty income and manufacturing revenues.

NXT-ID Inc (NXTD)   Day 2
Industry Sector: Technology - Media and Internet

NXT-ID is an emerging growth technology company that is focused on products, solutions, and services for security and convenience on mobile devices and the Internet of Things (IoT). Our core technologies consist of those that support digital payments, biometric identification, encryption, sensors, and miniaturization. We have three distinct lines of business that we are currently pursuing: mobile commerce, primarily through the application of secure digital payment technologies; biometric access control applications, and Department of Defense contracting. Our initial efforts have primarily focused on the development of our secure products for the growing m-commerce market, most immediately, a secure mobile electronic smart wallet, the Wocket®. The Wocket® is a smart wallet, designed to protect your identity.

Ocean Power Technologies
Ocean Power Technologies (OPTT)   Day 1
Industry Sector: Energy and Natural Resources

Headquartered in Pennington, New Jersey, Ocean Power Technologies is a pioneer in ocean wave energy conversion. OPT's proprietary PowerBuoy® technology is based on a scalable and modular design which allows for flexibility in meeting customer power requirements. OPT specializes in cost-effective and environmentally sound ocean wave based power generation and energy storage technology.

Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. (Private)   Day 2
Industry Sector: Life Science and Healthcare

Omnitura is a development stage biopharmaceutical company focused on developing orally delivered, non-toxic, multivalent immuno-oncology drugs for cancer. Omnitura's platform is based on the concept that cancer is a complex and multifaceted disease, and should be treated as such. Over the past 15 years our R&D efforts have shown Aneustat™, our lead drug candidate, to be non-toxic and pharmacodynamically active, and when given alone or in combination with standard therapies should improve late-stage cancer patient survival and safety. In addition, this treatment paradigm could serve to reduce recurrence and intercept early-stage disease. We are focused on bringing our lead drug candidate, Aneustat™, to market while leveraging our proprietary drug development platform and Multicision™ manufacturing quality control system.

Original SoupMan
Sponsoring Presenting Company
Original SoupMan (SOUP)   Day 1
Industry Sector: Retail and Consumer Products

Since 1984, the Original SoupMan has defined excellence and imagination in the art of soup. Our tiny outpost on 55th Street in Manhattan generated such loyalty and lines that "Seinfeld" memorialized the phenomenon in a famous episode. Now, more than 25 years later, a talented and experienced management team is creating a multi-channel national brand that produces small-batch soups that live up to their Zagat and Consumer Reports "Best" ratings. We reach discerning consumers through supermarket distribution, franchised restaurants, and our ecommerce-enabled website.

SoupMan Inc.'s wholly owned subsidiary, The Original SoupMan Inc. is a leading national brand in premium soup category.

Paringa Resources Ltd
Paringa Resources Ltd (PNGZF)   Day 1
Industry Sector: Energy and Natural Resources

Paringa Resources Limited  is an emerging US-based energy provider developing the high margin, low capex Buck Creek Mining Complex located in the growing Illinois Coal Basin (“ILB”). The Buck Creek Mining Complex is located in the Western Kentucky region of the ILB which is one of the most prolific coal producing regions in the US and is one of the last remaining large-scale undeveloped coal deposits in the ILB with direct low cost barge access to the Ohio River coal market, which is not controlled by a major coal producer.

Patriot Software Company
Sponsoring Presenting Company
Patriot Software Company (Private)   Day 1
Industry Sector: Technology - Media and Internet

Patriot Software Company provides fast, simple, and affordable software services to the North American small and mid-sized business markets. The company offers cloud-based accounting software, cloud-based payroll software and services, cloud-based recruitment and applicant tracking system (ATS) software, and contract staffing services in “software as a service” (SaaS) format. Formed in 1986 and beginning its thirtieth year, Patriot Software Company has been profitable since inception and remains debt-free. Patriot Software Company has two main subsidiaries, Patriot Software, Inc. and Top Echelon, Inc. Patriot Software Inc. has approximately 120 employees at its Canton, Ohio headquarters, with an additional 285 employees in 49 states.

PAVmed (PAVMU)   Day 2
Industry Sector: Life Science and Healthcare

PAVmed Inc. is an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The Company’s goal is to enhance and accelerate value creation by employing a business model focused on capital efficiency and speed to market. PAVmed is building a deep development product pipeline with attractive regulatory pathways and market opportunities encompassing a broad spectrum of clinical areas including carpel tunnel syndrome, medical infusions, interventional radiology, tissue ablation, and cardiovascular intervention. The Company is further expanding its pipeline through engagements with clinician innovators and leading academic medical centers.

PCM, Inc.
PCM, Inc. (PCMI)   Day 2
Industry Sector: Technology - Media and Internet

PCM, Inc. is a leading multi-vendor provider of technology products, services and solutions offered through our dedicated sales force, field and internal service teams, direct marketing channels and state of the art owned and operated data centers. Since our founding in 1987, we have served our customers by offering products and services from vendors such as Adobe, Apple, Cisco, Dell, Hewlett Packard Enterprise, HP Inc., Lenovo, Microsoft, Samsung, Symantec and VMware. We add additional value by incorporating products and services into comprehensive solutions. Our sales and marketing efforts allow our vendor partners to reach multiple customer segments including small, medium and enterprise businesses, state, local and federal governments and educational institutions.

PeerLogix Inc.
PeerLogix Inc. (LOGX)   Day 2
Industry Sector: Technology - Media and Internet

At PeerLogix, a publicly traded advertising technology and data aggregation provider, we’ve created a comprehensive digital media platform that helps advertisers and marketers reach, measure and activate the under-served audience of 140 million Torrent users worldwide. Beginning now, and only with PeerLogix, marketers can drive improved campaign performance, lift business results across any desired outcome, and re-engage these people whom we’re declaring are at the forefront of the Content-Sharing Economy.

PEN Inc.
PEN Inc. (PENC)   Day 1
Industry Sector: Life Science and Healthcare

At PEN, we're harnessing nanotechnology, the science of the infinitely small, in products that have big impact on health, safety and sustainability. They perform better, faster, smarter, stronger, cleaner – to make every day better for people and the planet. From healthcare to homecare, homeland defense to food security, transportation to recreation, products from our family of companies are transforming the way we live, work and play.

Petroshare Corp
Petroshare Corp (PRHR)   Day 1
Industry Sector: Energy and Natural Resources

Petroshare Corp is a Denver, CO based energy company targeting economic, unconventional resource plays that generate solid returns on capital deployed at current commodity pricing of $35 per barrel of oil. The Company is focused on asset acquisition and development in quality core areas in the Niobrara / Codell fairway of the DJ Basin in NE Colorado. Petroshare's industry veterans have successfully navigated previous commodity down cycles and have the expertise to capitalize on acquisition opportunities. With low G&A, capital is applied to drilling, completion and production infrastructure rather than support of an over levered balance sheet. Petroshare safely and efficiently develops projects with low impact and minimal surface footprint. Multi-well pad facilities, designed and constructed with all stakeholders in mind, utilize subsurface pipelines to deliver product to market with less traffic and fewer surface storage facilities.

PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. (PMBC)   Day 2
Industry Sector: Life Science and Healthcare

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box®".

PharmaCyte's treatment for cancer involves encapsulating genetically modified live cells capable of converting an inactive chemotherapy drug (ifosfamide) into its "cancer-killing" form. These encapsulated live cells are placed as close to a cancerous tumor as possible. Once implanted in a patient, ifosfamide is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been placed. When ifosfamide, which is normally activated in the liver, comes in contact with the encapsulated live cells, activation of the drug takes place at the source of the cancer without any side effects from the chemotherapy. This "targeted chemotherapy" has proven remarkably same and effective to use in past clinical trials.

PharmaCyte is also developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and secrete insulin at levels in proportion to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology.

PositiveID Corporation
PositiveID Corporation (PSID)   Day 1
Industry Sector: Life Science and Healthcare

PositiveID Corporation is a life sciences tools and diagnostics company, with an extensive patent portfolio, that specializes in biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. PositiveID develops microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need. The Company's Firefly Dx is a handheld pathogen detection system that uses real-time PCR chemistry to identify biological threats at the point of need in less than 30 minutes. PositiveID is also a leader in the mobile technology vehicle market, through its E-N-G Mobile Systems subsidiary, with a focus on the laboratory market, communications, and homeland security. The Company's Thermomedics subsidiary markets the FDA-cleared Caregiver® non-contact thermometer, which features TouchFree technology and is targeting the fastest growing segment of the temperature monitoring device market.

Powerstorm ESS
Powerstorm ESS (PSTO)   Day 1
Industry Sector: Energy and Natural Resources

At PowerstormESS, we sell more than batteries. We build advanced modular energy storage systems that provide economic & energy resilience for businesses, cities, and society – saving money, generating revenue, increasing resilience, and optimizing energy usage. We have decades of experience in battery system design and manufacturing, and use that expertise to provide you with turn-key solutions.

Our zeroXess platform is offering energy-efficient, high quality off-grid appliances to this expanding market where it will be well positioned for brand loyalty and sales growth. Tackling energy poverty will have less to do with ambitious expansion of electricity capacity, and more to do with ambitious distribution of energy services to poor people" We have to embrace failure and almost get a kick out of it. Not in a perverse way, but in a problem-solving way.

Pressure BioSciences, Inc.
Pressure BioSciences, Inc. PBIO   Day 1
Industry Sector: Life Science and Healthcare

Pressure BioSciences, Inc. develops, markets, and sells proprietary laboratory instrumentation and consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and high levels to safely and reproducibly control bio-molecular interactions. Over 250 PCT systems have been installed in about 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.

Primary PCT applications are in the biomarker discovery, drug discovery & design, and forensics areas. Our products are also used in bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.

In January 2016, we announced an exclusive, two-year co-marketing agreement with SCIEX, a global leader in life sciences analytical technologies.

Progressive Care, Inc.
Progressive Care, Inc. (RXMD)   Day 1
Industry Sector: Life Science and Healthcare

Progressive Care, Inc. through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities. Progressive Care is a growth stage company with approximately $14 million in annual revenues and market cap of $11 million. The Company is expanding rapidly by increasing it marketing presence, developing new custom compounds, pursuing pharmacy licenses in all 50 states and evaluating several merger and acquisition targets. The Company expects to build cash and deliver earnings by the end of 2016.

Provectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals, Inc. (PVCT)   Day 2
Industry Sector: Life Science and Healthcare

Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies. PV-10 is a novel investigational drug for cancer: melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company's other clinical trials can be found at the NIH registry,

Provision Holding, Inc.
Provision Holding, Inc. (PVHO)   Day 2
Industry Sector: Technology - Media and Internet

Provision Interactive Technologies, Inc., a subsidiary of the publicly traded company Provision Holding, Inc. (OTCQB: PVHO), is the leading purveyor of intelligent interactive 3D holographic display technologies, software, and integrated solutions for both commercial and consumer focused applications.

Provision's 3D holographic display systems represent a revolutionary technology that provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. Provision is currently the market leader in true 3D consumer advertising display products being implemented by innovative, consumer-focused companies.

Pulmatrix (PULM)   Day 2
Industry Sector: Life Science and Healthcare

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for lung disease patients. In addition, Pulmatrix is pursuing opportunities in major pulmonary diseases through collaborations, including PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease (COPD). Pulmatrix's product candidates are based on iSPERSE™, its proprietary dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.

PURE Bioscience, Inc.
PURE Bioscience, Inc. (PURE)   Day 2
Industry Sector: Life Science and Healthcare

PURE Bioscience, Inc. is commercializing its patented SDC-based antimicrobial products (FDA approved PURE Control® and EPA registered PURE® Hard Surface) providing less toxic and more effective food safety solutions for food processors/manufacturers, retailers and restaurants. SDC (silver dihydrogen citrate) test data demonstrate proven superior efficacy over a broad spectrum of pathogens, including E. coli, Salmonella, Listeria and Norovirus, when compared with toxic products currently in use in the food industry. The processing aids markets for fresh produce and for raw poultry represent a $650 million US opportunity for PURE Control. The growing US food-safety-solutions industry is a $2+ billion total opportunity and it is PURE’s 3–5 year goal to achieve at least 10+ % share of these markets to prevent foodborne illnesses. PURE is headquartered in El Cajon, California (San Diego metropolitan area).

Pyxis Tankers Inc
Pyxis Tankers Inc (PXS)   Day 2
Industry Sector: Industrials

Pyxis Tankers Inc. is an emerging growth pure play product tanker company. We own a modern fleet of six tankers engaged in seaborne transportation of refined petroleum products and other bulk liquids. We are focused on growing our fleet of medium range product tankers, which provide operational flexibility and enhanced earnings potential due to their "eco" features and modifications. We are well positioned to opportunistically expand and maximize our fleet due to competitive cost structure, strong customer relationships and experienced management team, whose interests are aligned with those of our shareholders.

Q BioMed Inc.
Q BioMed Inc. (QBIO)   Day 2
Industry Sector: Life Science and Healthcare

Q BioMed Inc. ''Q`` is a biomedical acceleration and development company. We are focused on acquiring undervalued biomedical assets. Q is dedicated to providing these target assets, strategic resources, developmental support, and expansion capital to accelerate developmental and ultimately, to provide products to patients in need‏.

Rand Capital Corporation
Rand Capital Corporation (RAND)   Day 1
Industry Sector: Financials and Asset Management Services

Rand Capital Corporation provides investors the ability to participate in venture capital opportunities through an investment in the Company’s stock. Rand is a Business Development Company (BDC), and its wholly-owned subsidiary is licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). Rand focuses its investments in early or expansion stage companies with strong leadership that are bringing to market new or unique products, technologies or services that have a high potential for growth.

Relmada Therapeutics Inc.
Relmada Therapeutics Inc. (RLMD)   Day 2
Industry Sector: Life Science and Healthcare

Relmada Therapeutics is a clinical-stage, publicly traded biopharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The Company has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol.

Rhino Resource Partners LP
Rhino Resource Partners LP (RHNO)   Day 1
Industry Sector: Energy and Natural Resources

Rhino Resource Partners LP (“Rhino”) is a master limited partnership that is focused on coal production and energy related assets and activities. Rhino produces, processes and sells high quality coal of various steam and metallurgical grades. Rhino markets its steam coal primarily to electric utility companies as fuel for their steam-powered generators. Customers for Rhino’s metallurgical coal are primarily steel and coke producers who use Rhino’s coal to produce coke, which is used as a raw material in steel manufacturing. Rhino’s recently announced joint venture with AMCI Group provides an opportunity to grow cash flow by providing exposure to specialty coal markets and customers where Rhino currently does not participate. In addition to operating coal properties, Rhino manages and leases coal properties through its Elk Horn subsidiary. Rhino believes its diversified energy portfolio along with a conservative capital structure positions it for long-term success in the energy market.

RiceBran Technologies
RiceBran Technologies (RIBT)   Day 1
Industry Sector: Life Science and Healthcare

RiceBran Technologies is a human ingredient and functional food company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. RiceBran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world’s most underutilized food sources, into a number of highly nutritious human food ingredients and functional foods. Our target markets include human food manufacturers, functional food and supplement manufacturers and animal nutrition manufacturers, both domestically and internationally. Additionally, RiceBran Technologies formulates and manufactures turnkey functional foods at our Healthy Natural, Inc. subsidiary. These finished product formulas utilize RiceBran Technologies’ proprietary and patented ingredients to target Nutraceutical and Functional Food markets worldwide.

SG Blocks
SG Blocks (SGBX)   Day 2
Industry Sector: Industrials

SG Blocks is the premier innovator of commercial and private environments utilizing code-engineered cargo shipping containers. Providing solutions to some of the world's biggest companies and government agencies, SG Blocks offers cost effective container-construction technology that exceeds many standard building code requirements. The Company works with developers, architects, builders and owners to achieve faster execution, stronger high-value buildings, and greener construction.

Soligenix, Inc.
Soligenix, Inc. (SNGX)   Day 2
Industry Sector: Life Science and Healthcare

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The BioTherapeutics division is developing three drug candidates. SGX301 (synthetic hypericin) for the early stage treatment of cutaneous T-cell lymphoma (CTCL) is currently enrolling patients in a Pivotal Phase 3 trial. The Phase 2 proof-of-concept study for SGX942, our novel innate defense regulator, demonstrated positive preliminary results in reducing the duration of severe oral mucositis in head and neck cancer patients. SGX203, a proprietary formulation of oral beclomethasone) is being developed for the front-line treatment of pediatric Crohn’s disease and will soon be initiating a Pivotal Phase 3 trial. The cornerstone of the vaccine/biodefense franchise is the ThermoVax® heat stabilization platform technology which eliminates cold chain production and storage concerns. The compounds in this division are fully funded through contracts from several US government agencies.

Spring Bank Pharmaceuticals Inc.
Spring Bank Pharmaceuticals Inc. (SBPH)   Day 2
Industry Sector: Life Science and Healthcare

Spring Bank Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company located outside of Boston, Massachusetts. The company discovers and develops small molecule nucleic acid hybrid (SMNH) compounds designed to selectively modulate cellular proteins to treat a variety of unmet medical needs. The company's lead development compound, SB 9200, is being evaluated in a global Phase 2a clinical study in non-cirrhotic patients infected with chronic HBV under a clinical collaboration with Gilead Sciences. Spring Bank believes SB 9200 may play an important role in antiviral therapy by modulating the body's immune response through its known mechanisms of action to fight viral infections. The Phase 2a is designed to evaluate SB9200 for treatment of HBV patients before receiving Viread (tenofivir). The World Health Organization estimates over 240 million people worldwide are chronically infected with HBV, including approximately 14 million people in the United States and Europe.

Staffing 360 Solutions, Inc.
Staffing 360 Solutions, Inc. (STAF)   Day 1
Industry Sector: Software and Business Services

Staffing 360 Solutions, Inc. is a high-growth public company in the staffing sector engaged in the execution of a global buy-and-build strategy through the acquisition of domestic and international staffing organizations in the US and the UK. The Company believes the staffing industry offers unique opportunities for accretive acquisitions that will drive its annual revenues to $300 million. As part of its targeted consolidation model, the Company is pursuing acquisition targets in the finance and accounting, administrative, engineering and IT staffing space. The company has already increased revenues from less than $1 million in fiscal 2013 to over $170 million on a current annualized basis. Management believes Staffing 360 Solutions is positioned to capitalize on the extraordinary demand for staffing services around the globe, with an unequivocal commitment to building long-term shareholder value.

Stealth Technologies
Stealth Technologies Private   Day 2
Industry Sector: Technology - Media and Internet

Stealth Technologies operations are focused on product development and sales in the Personal Security Protection and Data Protection businesses. Utilizing Stealth's technologies we  provide companies and individuals with new information protection solutions.  Stealth Card, designed to protect the RFID chip in a consumer's credit card from "electronic pickpocketing" that uses a smartphone, credit card reader, or RFID antenna to remotely access data stored on the consumer's "Smartchip". Stealth Technologies is focused on building an array of technology around protecting the consumer's data from current and future potentially compromising events.

StemCells, Inc.
StemCells, Inc. (STEM)   Day 1
Industry Sector: Life Science and Healthcare

StemCells, Inc. is engaged in the research and development of therapeutics using the Company's proprietary human neural stem cells for treating disorders of the central nervous system. The Company has completed four Phase I/II clinical trials including one in dry age related macular degeneration and one in spinal cord injury. The Company has reported positive results in both of these studies. The Company currently is pursuing a follow on Phase II study in chronic cervical spinal cord injury. Interim results on the first six patients in Cohort I of the spinal cord injury studies showed gains in muscle strength in 5 of the 6 patients. Four of those 5 subjects also demonstrated improved performance on functional tasks assessing dexterity and fine motor skills. In addition four of the six patients had improvement in the anatomic level of injury as defined by the ISNCSCI assessment of at least one level. Final results from this Cohort will be available second quarter 2016 with final study results available 2017.

SunGame Corporation
SunGame Corporation (SGMZ)   Day 1
Industry Sector: Technology - Media and Internet

Sungame Corporations business lines center around 3D hardware and software and associated technologies such as Virtual Reality for the mobile market. Sungame markets the "Flightdeck" Glasses-Free 3D Android tablet which has given the company specific expertise and experience related to the rapidly growing Virtual Reality (VR) industry. Sungame's proprietary software, originally developed for it's line of stereoscopic 3D mobile devices is now able to provide users with the ability to create and experience VR content. The company believes that the most promising and lucrative use of VR is for e-commerce and its "Vimarket" marketplace aims to be a leading portal for users and developers to access and publish VR content. Finally Sungame's community aims to become the premier destination for VR users to share content and collaborate with each other.

Sysorex Global Holdings Corp.
Sysorex Global Holdings Corp. (SYRX)   Day 1
Industry Sector: Technology - Media and Internet

Sysorex Global Holdings Corp. is a leading provider of Information Technology Support Services for enterprise level IT environments including full life cycle software development, interface, integration, operational support, and IT Network Infrastructure Modernization Services. With over 30 years of operating history, they provide a wide range of consulting, systems engineering, cyber security, data analytics and program management expertise.

Tapimmune Inc.
Tapimmune Inc. (TPIV)   Day 2
Industry Sector: Life Science and Healthcare

TapImmune Inc. is a clinical stage immunotherapy company specializing in the development of innovative technologies for the treatment of cancer, including metastases, and infectious disease. The Company’s peptide or nucleic acid-based immunotherapeutics, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patient’s killer T–cells, helper T–cells and to restore or further augment antigen presentation using proprietary nucleic acid-based expression systems.

TapImmune has completed Phase I studies at the Mayo Clinic in HER2/neu breast cancer and in ovarian and triple-negative breast cancer with a large majority of patients showing T–cell immune responses against the vaccine antigens. Phase II studies on a Folate Receptor Alpha peptide vaccine for the treatment of triple-negative breast cancer are scheduled to start later in 2015.

The Company’s technologies may be used as stand-alone medications or in combination with current treatments.

Tecogen Inc.
Tecogen Inc. (TGEN)   Day 1
Industry Sector: Energy and Natural Resources

Tecogen® Inc. is a leading provider of cost efficient, clean and reliable products for power production, heating and cooling which, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. With over 2,300 units shipped, Tecogen technology is revolutionizing distributed generation for customers in the $40B small-to-mid size Combined Heat and Power (CHP) market segment.

Terra Tech Corp
Terra Tech Corp (TRTC)   Day 1
Industry Sector: Retail and Consumer Products

Terra Tech Corp is a vertically integrated, cannabis-focused agriculture company. Through its subsidiary, MediFarm, Terra Tech cultivates and produces medical cannabis. The Company recently launched its IVXXTM brand of high-quality medical cannabis produced in Company-owned labs and sold in select dispensaries throughout California and Nevada. The Company has also recently opened its first medical cannabis dispensaries, under the name Blüm, in California and Nevada which offer a broad selection of the highest quality medical cannabis products to patients, including flowers, concentrates and edibles.

Through its wholly-owned subsidiary, Edible Garden, Terra Tech cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Walmart, Krogers, and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania and the Midwest

TESSCO Technologies Inc.
TESSCO Technologies Inc. (TESS)   Day 1
Industry Sector: Technology - Media and Internet

For nearly three decades, TESSCO Technologies Incorporated has been proving its position as an industry-leading, total source provider to the ever-evolving global wireless marketplace. As a trusted industry veteran, TESSCO makes wireless work for wireless system operators, program managers, contractors, utility, transportation, enterprise and government organizations, and resellers – delivering the innovative product + value chain solutions they need to deploy and support wireless systems.

Theralase Technologies Inc.
Theralase Technologies Inc. (TLTFF)   Day 1
Industry Sector: Life Science and Healthcare

Theralase Technologies Inc. ("Theralase®") in its Therapeutic Laser Technology ("TLT") Division designs, manufactures and markets patented super-pulsed laser technology indicated for the: elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase's Photo Dynamic Therapy ("PDT") Division researches and develops specially designed molecules called Photo Dynamic Compounds ("PDCs"), which are able to localize to cancer cells and then when laser light activated, effectively destroy them.

U.S. Geothermal Inc.
U.S. Geothermal Inc. (HTM)   Day 1
Industry Sector: Energy and Natural Resources

U.S. Geothermal Inc., is a leading and profitable renewable energy company focused on the development, production and sale of electricity from geothermal energy. The Company is currently operating geothermal power projects at Neal Hot Springs, Oregon, San Emidio, Nevada and Raft River, Idaho for a total power generation capacity of approximately 45 megawatts. The Company has advanced stage development projects at the Geysers, in California, and a second phase project at San Emidio, Nevada and El Ceibillo, located near Guatemala City, Guatemala. Exploration projects include Crescent Valley, Nevada, and Vale, Oregon. U.S. Geothermal’s growth strategy is to reach 200MW’s of production by 2020, through a combination of internal development and strategic acquisitions.

VBI Vaccines Inc.
VBI Vaccines Inc. (VBIV)   Day 1
Industry Sector: Life Science and Healthcare

VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI's eVLP vaccine platform allows for the design of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus. The company's lead eVLP asset is a prophylactic Cytomegalovirus ("CMV") vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company's second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI has completed proof of concept thermostability studies on a number of vaccine and biologic targets. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.

Viking Therapeutics
Viking Therapeutics (VKTX)   Day 1
Industry Sector: Life Science and Healthcare

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The company's lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, in Phase 2 development for the treatment and prevention of lean body mass loss in patients who have undergone hip fracture surgery, and VK2809, a small molecule thyroid beta agonist entering Phase 2 development for hypercholesterolemia and fatty liver disease. Viking is also developing novel and selective agonists of the thyroid beta receptor for adrenoleukodystrophy, as well as two earlier-stage programs targeting metabolic diseases and anemia.

Village Farms International
Village Farms International (VFFIF)   Day 1
Industry Sector: Retail and Consumer Products

Village Farms is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America.This premium product as well as premium product produced under exclusive arrangements with other greenhouse producers is grown in sophisticated, highly efficient and intensive agricultural greenhouse facilities located in British Columbia and Texas.Product is marketed and distributed under the Village Farms® brand primarily to retail grocers and dedicated fresh food distributors throughout the United States and Canada.Since its inception, Village Farms has been guided by sustainable growing methods and producing vegetables 365 days a year from its facilities that are healthier for people and the planet.Village Farms is Good for the Earth®.

Vishay Precision Group, Inc.
Vishay Precision Group, Inc. (VPG)   Day 1
Industry Sector: Industrials

Vishay Precision Group, Inc. (VPG) is an internationally recognized designer, manufacturer and marketer of: components based on its resistive foil technology; sensors; and sensor-based systems specializing in the growing markets of stress, force, weight, pressure, and current measurements. VPG is a market leader of foil technology products, providing ongoing technology innovations in precision foil resistors and foil strain gages, which are the foundation of the company's force sensors products and its weighing and control systems. The product portfolio consists of a variety of well-established brand names recognized for precision and quality in the marketplace.

VolitionRx Limited
VolitionRx Limited (VNRX)   Day 1
Industry Sector: Life Science and Healthcare

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

Weyland Tech, Inc.
Weyland Tech, Inc. (WEYL)   Day 1
Industry Sector: Technology - Media and Internet

Weyland Tech's CreateApp platform enables small-medium-sized businesses ("SMB's") to create a mobile application ("app") without the need of technical knowledge and background. The CreateApp platform is offered in 11 languages and 48 functions, creating a simple, easy-to-use app for business owners to engage customers.

SMB's can increase sales, reach more customers and promote their products and services via a simple easy to build mobile app at an affordable and cost-effective manner.

The underlying dynamics of the Southeast and South Asia markets, where the Company has a focus, create a compelling opportunity for Weyland Tech to grow significantly - SMB's in both regions, as a percentage of total businesses, exceed 95%.

Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (XTNT)   Day 1
Industry Sector: Life Science and Healthcare

Xtant Medical Holdings, Inc. develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.

Zedge, Inc.
Zedge, Inc. (ZDGE)   Day 1
Industry Sector: Technology - Media and Internet

Zedge provides one of the most popular content distribution platforms, worldwide, centered on self-expression, attracting both creators and brands looking to promote their content to consumers who utilize such content to express their identity, feelings, tastes and interests. Our platform enables consumers to personalize their mobile devices with free, high quality ringtones, wallpapers, app icons and notification sounds. Zedge's app, available in Google Play and iTunes has been installed over 200 million times, has more than 32 million monthly active users and has averaged among the top 25 free applications in the Google Play store in the U.S. for the past six years and is ranked in the top 10 most popular free apps in the iTunes Entertainment category. Zedge has grown organically without material investment in user acquisition, advertising or marketing. Zedge generates its revenues from advertising and is profitable with $1.6 million in net income in FY '15.

* Important note about presenting companies

The information contained on this website should not be construed as an endorsement of any entity included herein, is not intended to be used, and cannot be used, for the purpose of promoting, marketing, or recommending to another party any transaction or matter. Neither the information nor the Marcum MicroCap Conference shall constitute an offer or the solicitation of an offer to sell or buy any security. Information about the presenting companies, and information contained on presenting company websites has been prepared by and is the responsibility of each of the individual presenting companies. Marcum has not reviewed such information and does not provide any assurance that such information is accurate or complete.
© 2016 Marcum LLP. All Rights Reserved.
Privacy | Legal | Sitemap |